Home / Share Price Target / Brawn
Brawn Biotech Share Price Target 2024, 2025, 2026 to 2039 With Charts
Brawn Biotech Limited | |||
 | Symbol: BRAWN | ||
| Price: ₹20.76 | |||
| Exchange: BSE | |||
| -> | |||
Show Table of Contents
Table of Contents
- 0.1: Brawn Biotech Financial Performance
- 0.1.1: Is Brawn Biotech A Good Buy For Long Term?
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Brawn Biotech Share Price Target For 2024
- 1.1.1: Brawn Biotech Share Price Target Table For 2024
- 1.1.2: Summary: Brawn Biotech Share Price Prediction For 2024
- 1.2: Brawn Biotech Share Price Target For 2025
- 1.2.1: Brawn Biotech Share Price Target Table For 2025
- 1.2.2: Summary: Brawn Biotech Share Price Prediction For 2025
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Brawn Biotech Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 2.2: Brawn Biotech Share Price Target Table From 2024, 2025, 2026 to 2039
- 3: Brawn Biotech Past Performance
Brawn Biotech Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 7.18 Crore | Market valuation of Brawn Biotech's shares. |
| Revenue (TTM) | 16.49 Crore | Total revenue generated by Brawn Biotech over the past twelve months. |
| Net Income (TTM) | -1.54 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | -9.34% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 12.91% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +17.91% | Change in revenue compared to the previous quarter. |
Is Brawn Biotech A Good Buy For Long Term?
Brawn Biotech, a small-cap stock with a market capitalization of 6.8 crore, presents a mixed picture for long-term investors. While its revenue reached 16.49 crore in the last twelve months (TTM), it incurred a net loss of 1.54 crore, resulting in a negative profit margin. Despite strong 12-month returns (36.61%), the past 5-year performance (-41.74%) reveals significant risk. The recent positive 3-month return (8.87%) and modest YTD return (1.36%) offer a glimmer of hope, but overall, Brawn Biotech is currently a not a good buy for long-term investors due to its consistent lack of profitability. Further investigation is warranted before considering any investment.
To predict the Brawn Biotech's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Brawn Biotech Share Price Target For 2024
The line chart displays the monthly closing prices of Brawn Biotech with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Brawn Biotech shares in 2024, see the table below.
Brawn Biotech Share Price Target Table For 2024
| Brawn Biotech's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 21.85 (+5.25%) | Price Action: Mar 2021 Low |
| 2024 Target 2 | 21.56 (+3.85%) | Custom Fibonacci Extension Lvl 64.9% |
| 2024 Target 1 | 21.30 (+2.6%) | Price Action: 21 Oct 2024 High |
| Current Price | 20.76 | Brawn Biotech's 1 share price as of Fri 22 Nov 2024 |
| Stop Loss 1 | 21.15 (+1.87%) | Price Action: Jul 2020 Low |
| Stop Loss 2 | 20.86 (+0.48%) | Fibonacci Retracement Extended 61.8% |
| Stop Loss 3 | 20.60 (-0.78%) | Price Action: Oct 2024 Low |
Summary: Brawn Biotech Share Price Prediction For 2024
In summary, Brawn Biotech has declined by ₹-0.87, recording a notable -3.97% decrease from 1st January 2024 to 22 Nov 2024. Despite the setback, our analysis of Brawn Biotech for 2024 predicts an additional rise of 2.6% to 5.25% by the end of 2024 with three potential targets T1: 21.30, T2: 21.56, T3: 21.85. Stop Loss at SL1: 21.15, SL2: 20.86, SL3: 20.60.
Brawn Biotech has a 52-week high of ₹27.82, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹14.63, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Brawn Biotech.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Brawn Biotech Share Price Target For 2025
The line chart displays the monthly closing prices of Brawn Biotech with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Brawn Biotech shares in 2025, see the table below.
Brawn Biotech Share Price Target Table For 2025
| Brawn Biotech's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 30.50 (+46.91%) | Fibonacci Extension Level 123.6% |
| 2025 Target 2 | 29.83 (+43.68%) | Price Action: Chart |
| 2025 Target 1 | 29.53 (+42.24%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 20.76 | Brawn Biotech's 1 share price as of Fri 22 Nov 2024 |
| Stop Loss 1 | 19.27 (-7.18%) | Price Action: 23 Oct 2024 Low |
| Stop Loss 2 | 19.05 (-8.24%) | Price Action: Oct 2021 Low |
| Stop Loss 3 | 18.80 (-9.45%) | Price Action: Jan 2024 Low |
Summary: Brawn Biotech Share Price Prediction For 2025
In summary, Brawn Biotech has declined by ₹-0.87, recording a notable -3.97% decrease from 1st January 2024 to 22 Nov 2024. Despite the setback, our analysis of Brawn Biotech for 2025 predicts an additional rise of 42.24% to 46.91% by the end of 2025 with three potential targets T1: 29.53, T2: 29.83, T3: 30.50. Stop Loss at SL1: 19.27, SL2: 19.05, SL3: 18.80.
Brawn Biotech has a All-Time high of ₹95.60, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹14.63, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Brawn Biotech, we have created a specific page for that check here: Brawn Biotech Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Brawn Biotech Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Brawn Biotech share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 0.26% over the next 15 years.
For complete year by year Brawn Biotech long term share price target from 2024, 2025 to 2039 check the below table.
Brawn Biotech Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Brawn Biotech Target | YoY Change % |
|---|---|---|
| 2024 | ₹20.76 | [Current Price] |
| 2024 | ₹20.26 | -2.41% |
| 2025 | ₹21.1 | 4.14% |
| 2026 | ₹20.82 | -1.33% |
| 2027 | ₹21.68 | 4.13% |
| 2028 | ₹20.61 | -4.94% |
| 2029 | ₹20.51 | -0.49% |
| 2030 | ₹21.36 | 4.14% |
| 2031 | ₹21.08 | -1.32% |
| 2032 | ₹21.95 | 4.12% |
| 2033 | ₹20.86 | -4.97% |
| 2034 | ₹20.77 | -0.44% |
| 2035 | ₹21.62 | 4.09% |
| 2036 | ₹21.33 | -1.35% |
| 2037 | ₹22.21 | 4.12% |
| 2038 | ₹21.12 | -4.91% |
| 2039 | ₹21 | -0.57% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Brawn Biotech Past Performance
- In 2009, Brawn Biotech opening price was ₹36
- As of Fri 22 Nov 2024 the price stands at ₹20.76.
- This represents a Compound Annual Growth Rate (CAGR) of -3.38%.
- In 15 years, an investment of 10,000 would have become ₹5,766.66.
As we wrap up, we hope you like our study on Brawn Biotech share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
